Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vasil Valov
Observed names:
V Valov,
V. Valov,
Valov, Vasil
Observed institution:
Medical University of Sofia
OpenAlex ID:
A5083014765
Life expectancy and survival analysis of patients with diabetes compared to the non diabetic population in Bulgaria
2020
·
Konstantin Tachkov
, Konstantin Mitov
, et al.
·
PLoS ONE
·
43
PDF
Cost-effectiveness of insulin degludec versus insulin glargine U100 in adults with type 1 and type 2 diabetes mellitus in Bulgaria
2019
·
Monika Russel-Szymczyk
, Vasil Valov
, et al.
·
BMC Endocrine Disorders
·
10
PDF
Cost of hospitalizations due to microvascular and macrovascular complications in type 1 and type 2 diabetic patients in Bulgaria
2015
·
Maria Dimitrova
, Miglena Doneva
, et al.
·
Biotechnology & Biotechnological Equipment
·
10
Comparative Analysis of the Cost of Insulin Treated Patients in Bulgaria
2013
·
Miglena Doneva
, Vasil Valov
, et al.
·
Biotechnology & Biotechnological Equipment
·
8
PDF
Regional differences in diabetic patients' pharmacotherapy in Bulgaria.
2014
·
V Valov
, M Doneva
, et al.
·
PubMed
·
6
Improved quality of diabetes control reduces complication costs in Bulgaria
2019
·
Konstantin Tachkov
, Konstantin Mitov
, et al.
·
Biotechnology & Biotechnological Equipment
·
4
PDF
Cost-Effectiveness of Biphasic Insulin Aspart 30 VS. Human Premix Insulin in Type 2 Diabetes from the Payer's Perspective in Bulgaria
2012
·
Vasil Valov
, James Palmer
, et al.
·
Biotechnology & Biotechnological Equipment
·
4
The cost of macro- and microvascular diseases in patients with diabetes mellitus in selected Central and Eastern European countries
2019
·
Justyna Grelewska
, Michał Jakubczyk
, et al.
·
Journal of Health Policy & Outcomes Research
·
3
PDF
Estimating The Cost of Diabetes-Related Cardiovascular Complications In Selected Central And Eastern European Countries
2017
·
J Ostrowska
, M Jakubczyk
, et al.
·
Value in Health
·
3
PDF
PHS87 Cost of Diabetes in Insulin-Treated Patients in Bulgaria
2012
·
M. Doneva
, V. Valov
, et al.
·
Value in Health
·
2
Medical, social, and economic consequences of type 2 diabetes therapy with medicinal products from the group of DPP-4i, SGLT-2i, and GLP-1 RA
2018
·
Zornitsa Mitkova
, Konstantin Mitov
, et al.
·
International Journal of Diabetes in Developing Countries
·
1
PDB29 Modeling the Impact of Enhanced Treatment of Type 2 Diabetes Mellitus in Bulgaria
2011
·
M. Boyanov
, G. Petrova
, et al.
·
Value in Health
·
1
Incretins and SGLT-2i Therapy of Type 2 Diabetes – Real Life Study of Their Therapeutic and Economic Effects
2019
·
Zornitsa Mitkova
, Konstantin Mitov
, et al.
·
Frontiers in Pharmacology
PDF
Pdb43 - the Costs and Results of Incretins’and Sglt-2i Diabetes Therapy in Bulgaria
2018
·
Z. Mitkova
, V. Valov
, et al.
·
Value in Health
Pdb61 Economic Evaluation of Liraglutide Vs. Rosiglitazone or Exenatide for Type 2 Diabetes Mellitus in Bulgaria
2010
·
A Ivanova
, G Petrova
, et al.
·
Value in Health
PDF
The need for quantitative indicators in studying prevalence, evolution and treatment of diabetes mellitus.
2010
·
Vasil Valov
, Михаил Michail Боянов Boyanov
·
Meditsinski Pregled / Medical Review
What is the cost of diabetes mellitus
2010
·
Mihail Boyanov
, Vasil Valov
·
Meditsinski Pregled / Medical Review
Show more works
View as search
Works count:
19
Citation count:
95
H-index:
5
I10-index:
3
Year
Topic
Type
